Proficio Capital Partners LLC Makes New Investment in AdaptHealth Corp. (NASDAQ:AHCO)

Proficio Capital Partners LLC purchased a new stake in AdaptHealth Corp. (NASDAQ:AHCO) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 19,040 shares of the company’s stock, valued at approximately $181,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Pacer Advisors Inc. acquired a new stake in AdaptHealth in the fourth quarter valued at about $76,271,000. Principal Financial Group Inc. lifted its holdings in shares of AdaptHealth by 204.0% in the fourth quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company’s stock worth $15,735,000 after acquiring an additional 1,109,021 shares during the last quarter. State Street Corp boosted its stake in shares of AdaptHealth by 19.8% in the 3rd quarter. State Street Corp now owns 4,124,284 shares of the company’s stock valued at $46,316,000 after purchasing an additional 681,816 shares in the last quarter. FMR LLC grew its holdings in shares of AdaptHealth by 9.3% during the 3rd quarter. FMR LLC now owns 7,350,549 shares of the company’s stock valued at $82,547,000 after purchasing an additional 624,645 shares during the last quarter. Finally, Segall Bryant & Hamill LLC increased its position in AdaptHealth by 15.5% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 3,701,808 shares of the company’s stock worth $41,571,000 after purchasing an additional 496,453 shares in the last quarter. Institutional investors own 82.67% of the company’s stock.

Wall Street Analysts Forecast Growth

AHCO has been the subject of several research analyst reports. Robert W. Baird upped their price target on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an “outperform” rating in a report on Thursday, February 27th. UBS Group lowered their target price on AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a report on Thursday, February 13th. Canaccord Genuity Group lifted their price target on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Royal Bank of Canada boosted their price target on AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a report on Wednesday, February 26th. Finally, Truist Financial raised their price objective on shares of AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a report on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $13.80.

AdaptHealth Trading Down 5.8 %

NASDAQ AHCO opened at $9.53 on Thursday. The firm has a market capitalization of $1.29 billion, a PE ratio of -5.78, a price-to-earnings-growth ratio of 1.08 and a beta of 1.30. The business’s 50-day moving average price is $10.02 and its two-hundred day moving average price is $10.24. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. AdaptHealth Corp. has a 12 month low of $8.35 and a 12 month high of $11.90.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.